Lindbrook Capital, LLC - PDS BIOTECHNOLOGY CORP ownership

PDS BIOTECHNOLOGY CORP's ticker is PDSB and the CUSIP is 70465T107. A total of 54 filers reported holding PDS BIOTECHNOLOGY CORP in Q2 2022. The put-call ratio across all filers is 0.36 and the average weighting 0.0%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of PDS BIOTECHNOLOGY CORP
ValueSharesWeighting
Q3 2023$2,525
+0.4%
5000.0%0.00%
Q2 2023$2,515
-18.2%
5000.0%0.00%
Q1 2023$3,075
-53.4%
5000.0%0.00%
-100.0%
Q4 2022$6,600
+560.0%
5000.0%0.00%
Q3 2022$1,000
-50.0%
5000.0%0.00%
Q2 2022$2,000
-33.3%
5000.0%0.00%
Q1 2022$3,000
-25.0%
5000.0%0.00%
-100.0%
Q4 2021$4,0005000.00%
Other shareholders
PDS BIOTECHNOLOGY CORP shareholders Q2 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 117,242$428,0000.28%
INSPIRION WEALTH ADVISORS, LLC 313,669$1,145,0000.25%
ACT CAPITAL MANAGEMENT, LLC 12,000$44,0000.06%
Sofinnova Investments, Inc. 142,635$521,0000.04%
KNIGHTSBRIDGE ASSET MANAGEMENT, LLC 44,362$162,0000.03%
XTX Topco Ltd 21,085$77,0000.03%
Andesa Financial Management Inc. 12,500$46,0000.03%
Virtu Financial LLC 47,326$173,0000.02%
Minot Wealth Management LLC 10,000$37,0000.01%
HAP Trading, LLC 25,500$160,0000.01%
View complete list of PDS BIOTECHNOLOGY CORP shareholders